Stockscreener 앱 받기
252.93
0.02%
0.06
시간 외 거래:
253.64
0.71
+0.28%
전일 마감가:
$252.87
열려 있는:
$250.08
하루 거래량:
1.05M
Relative Volume:
1.02
시가총액:
$36.85B
수익:
$5.40B
순이익/손실:
$1.49B
주가수익비율:
25.00
EPS:
10.1168
순현금흐름:
$1.78B
1주 성능:
-1.73%
1개월 성능:
-8.35%
6개월 성능:
-9.41%
1년 성능:
+8.82%
1일 변동 폭
$246.17
$253.13
1주일 범위
$246.17
$260.22
52주 변동 폭
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
명칭
Resmed Inc
전화
(858) 746-2400
주소
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Compare RMD vs ISRG, BDX, ALC, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
252.93 | 36.84B | 5.40B | 1.49B | 1.78B | 10.12 |
|
ISRG
Intuitive Surgical Inc
|
493.56 | 174.07B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
165.46 | 47.54B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
81.85 | 39.64B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
43.41 | 35.57B | 28.43B | 1.16B | 1.26B | 1.4457 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-09-18 | 개시 | Citigroup | Buy |
| 2025-09-02 | 업그레이드 | CLSA | Hold → Outperform |
| 2025-07-15 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | 개시 | Morgan Stanley | Overweight |
| 2025-01-16 | 개시 | Goldman | Buy |
| 2025-01-10 | 개시 | Piper Sandler | Neutral |
| 2024-12-13 | 개시 | Stifel | Hold |
| 2024-09-24 | 개시 | Robert W. Baird | Outperform |
| 2024-09-18 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | 다운그레이드 | Needham | Buy → Hold |
| 2024-06-25 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-06-24 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-09-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | 업그레이드 | Needham | Hold → Buy |
| 2023-09-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-08-01 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 개시 | UBS | Buy |
| 2023-04-14 | 개시 | Mizuho | Buy |
| 2023-01-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-10-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-20 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-09-08 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-08-15 | 다운그레이드 | CLSA | Buy → Outperform |
| 2022-08-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-08-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-01-31 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-01-28 | 업그레이드 | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-01-13 | 업그레이드 | CLSA | Outperform → Buy |
| 2022-01-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | 업그레이드 | Macquarie | Neutral → Outperform |
| 2021-10-22 | 업그레이드 | CLSA | Underperform → Outperform |
| 2021-08-02 | 다운그레이드 | CLSA | Outperform → Sell |
| 2021-08-02 | 다운그레이드 | Needham | Buy → Hold |
| 2021-07-28 | 업그레이드 | Jefferies | Underperform → Hold |
| 2021-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 개시 | RBC Capital Mkts | Underperform |
| 2021-06-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-06-22 | 업그레이드 | Macquarie | Neutral → Outperform |
| 2021-06-22 | 개시 | Robert W. Baird | Neutral |
| 2021-06-21 | 재확인 | Needham | Buy |
| 2021-06-16 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-06-09 | 업그레이드 | CLSA | Sell → Outperform |
| 2021-05-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-04-30 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-03-16 | 업그레이드 | Needham | Hold → Buy |
| 2020-11-02 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-30 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2020-10-27 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-01 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 개시 | CLSA | Underperform |
| 2020-01-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Perform |
| 2019-11-22 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | 업그레이드 | UBS | Neutral → Buy |
| 2019-07-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-05-06 | 업그레이드 | UBS | Neutral → Buy |
| 2019-04-18 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-01-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2019-01-25 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-10-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 개시 | Goldman | Buy |
모두보기
Resmed Inc 주식(RMD)의 최신 뉴스
Healthcare Sector Analysis: Natera, ResMed, Globus Medical Driving InnovationNews and Statistics - IndexBox
First Trust Advisors LP Buys 329,588 Shares of ResMed Inc. $RMD - MarketBeat
Neuberger Berman Group LLC Boosts Position in ResMed Inc. $RMD - MarketBeat
Blair William & Co. IL Trims ResMed Inc. Stake - National Today
Dimensional Fund Advisors LP Has $231.59 Million Stock Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Sold by Blair William & Co. IL - MarketBeat
Crossmark Global Holdings Inc. Purchases 17,487 Shares of ResMed Inc. $RMD - MarketBeat
Marietta Investment Partners LLC Invests $2.70 Million in ResMed Inc. $RMD - MarketBeat
Resmed director Farrell sells $520k in stock - Investing.com
Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RM - GuruFocus
ResMed Director Peter Farrell Plans Modest Insider Share Sale Under Rule 144 - TipRanks
ResMed (NYSE:RMD) Director Peter Farrell Sells 2,000 Shares - MarketBeat
ResMed Inc. $RMD Shares Sold by Victory Capital Management Inc. - MarketBeat
Quantbot Technologies LP Reduces Stock Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Purchased by Fisher Asset Management LLC - MarketBeat
ResMed Updates CDI Count Amid Cross-Market Transfers and Buybacks - TipRanks
ResMed CFO Sandercock Sells 1,000 Shares Under Pre-Set Trading Plan - TipRanks
Insider Sell Alert: Brett Sandercock Sells Shares of ResMed Inc (RMD) - GuruFocus
ResMed Executive Files Rule 144 Notice for Routine Share Sales - TipRanks
ResMed (NYSE: RMD) CFO sells 1,000 shares in Rule 10b5-1 trade - Stock Titan
Final Trades: Toast, Disney, ServiceNow and ResMed - CNBC
Mitsubishi UFJ Asset Management Increases ResMed Stake - National Today
Elo Mutual Pension Insurance Co Raises Stock Position in ResMed Inc. $RMD - MarketBeat
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach - Koreabizwire
Resmed Reveals Growing Global Awareness of Sleep Health Amid Action Gap in Latest Survey Findings - Quiver Quantitative
People say sleep matters most for health, yet quality rest is rare - Stock Titan
Andra AP fonden Cuts Stake in ResMed Inc. - National Today
RMD (NYSE: RMD) broker files Rule 144 notice for 1,000 shares - Stock Titan
Sleep apnea specialist Resmed announces plans for major new distribution centre - Mugglehead Investment Magazine
ResMed Inc. (RMD) Stock Analysis: Exploring a 16% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Andra AP fonden Cuts Stock Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc.: The Sleep-Tech Stock You Should Not Ignore in 2026 - AD HOC NEWS
RMD PE Ratio & Valuation, Is RMD Overvalued - Intellectia AI
RMD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ResMed Greenwood Hub Aims To Tighten Supply Chain And Patient Access - Sahm
Mitsubishi UFJ Asset Management Increases Stake in ResMed - National Today
Mitsubishi UFJ Asset Management Co. Ltd. Raises Holdings in ResMed Inc. $RMD - MarketBeat
Intech Investment Management LLC Has $8.57 Million Holdings in ResMed Inc. $RMD - MarketBeat
Sleep Tech Demand Fuels ResMed - AlphaStreet News
ResMed Expands Greenwood Hub As Investors Weigh Valuation And Soft Momentum - Yahoo Finance
ResMed Inc (NYSE:RMD): A Durable Dividend Stock Built on Financial Strength - ChartMill
The Bull Case For ResMed (RMD) Could Change Following New Greenwood Distribution Hub Plan – Learn Why - simplywall.st
Dakota Wealth Management Grows Stake in ResMed Inc. $RMD - MarketBeat
Is ResMed Stock A Trap Or A Missed Opportunity? - Trefis
Why I would buy ResMed and these quality blue chips now - The Motley Fool Australia
Is ResMed Stock Poised for a Rally? - Trefis
Shares of Resmed Fall 3% After Declaring Plan to Open New US Distribution Center - marketscreener.com
ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch
Resmed to open new distribution center in Indiana - MassDevice
ResMed Greenwood Hub Aims To Tighten Logistics And Support Growth - simplywall.st
Braun: Resmed to build $30 million facility in Greenwood - Fox 59
Resmed Inc (RMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
0.64%
자본화:
|
볼륨(24시간):